What is Rossari Biotech Ltd (ROSSARI) share price return in the past 10 years?

Data is not available for this company

What is the share price of Rossari Biotech Ltd (ROSSARI)?

Company share prices are keep on changing according to the market conditions. The current trading price of Rossari Biotech Ltd (ROSSARI) on 02-Jul-2026 16:59:59 at 16:59 is 523.70.

What is the P/E ratio of Rossari Biotech?

The latest standalone P/E ratio of Rossari Biotech as of 02-Jul-2026 is 20.31.

What is the P/B ratio of Rossari Biotech Ltd (ROSSARI)?

The latest standalone P/B ratio of Rossari Biotech Ltd (ROSSARI) as of 02-Jul-2026 is 2.39.

What is the 52-week high and low of Rossari Biotech Ltd (ROSSARI)?

The 52-week high of Rossari Biotech Ltd (ROSSARI) is Rs. 767.55 and the 52-week low is Rs. 372.90.

Rossari Biotech Ltd (ROSSARI) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Rossari Biotech Ltd (ROSSARI)
Brand: Rossari Biotech

Key Metrics

Valuation Multiples

Market Cap

₹2,901 Cr.

Current Price

₹523.7

52-Week Low / High

₹373 / 768

TTM EPS

₹26.9

TTM Sales

₹2,396 Cr.

Book Value per Share

₹239.7

P/E Ratio

19.44

Lower than its 5-year historical median

Industry PE

52.9

Price to Book (P/B)

2.18

Lower than its 5-year historical median

Price to Sales (P/S)

1.21

Lower than its 5-year historical median

EV/EBITDA

10.43

Lower than its 5-year historical median

Dividend Yield

0.1%

Profitability Efficiency

Return on Equity (ROE)

11.88%

Outperforms industry median

Return on Capital Employed (ROCE)

14.84%

Outperforms industry median

Return on Assets (ROA)

6.16%

Operating Profit Margin

11.2%

Net Profit Margin

6.23%

Gross Profit Margin

11.6%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

15.19%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

5.85%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

9.41%

Asset Quality

Promoter Holding

68.15%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹1,317 Cr.

Equity

₹11.1 Cr.

Face Value

₹2

All Time Low / High

₹372.90 / 1620.60

Rossari Biotech stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Rossari Biotech Ltd a good quality company?

Rossari Biotech Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Rossari Biotech Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Rossari Biotech Ltd vs industry peers?

Rossari Biotech Ltd revenue CAGR is 28.23%, compared to the industry median CAGR of 7.53%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Rossari Biotech Ltd?

Promoters hold 68.15% of the Rossari Biotech Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Rossari Biotech Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of -14.68% based on the current price.

DeciZen - make an informed investing decision on Rossari Biotech

Consolidated basis

1. Right Stock

2. Right Price

Price Chart

3. Right Time ⓘ

#Likely Future 5 Year CAGR.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
ROCE % ⓘ	26.4%	40.4%	54.4%	37.9%	28.8%	24.4%	18.5%	18.4%	16.1%	14.8%	-
Value Creation Index ⓘ	0.9	1.9	2.9	1.7	1.1	0.8	0.3	0.3	0.2	0.1	-
Growth Parameters ⓘ
Sales ⓘ	233	292	516	600	709	1,483	1,656	1,831	2,080	2,396	2,396
Sales YoY Gr.	-	25%	76.9%	16.3%	18.2%	109.1%	11.7%	10.6%	13.6%	15.2%	-
Adj EPS ⓘ	3.3	5.9	9.5	12.6	15.3	16.3	18.3	22.6	23.3	22.3	26.9
YoY Gr.	-	81.9%	60.1%	33.1%	21.8%	6%	12.9%	23.1%	3.1%	-4%	-
BVPS (₹) ⓘ	13.5	19.5	25.6	56.4	78.3	145.7	165.3	189	213.7	239.8	239.7
Adj Net Profit ⓘ	15.7	28.6	45.8	63.9	79.6	89.5	101	125	129	124	149
Cash Flow from Ops. ⓘ	7.2	23.6	71.2	56.8	47.8	29.4	152	43.3	137	65.1	-
Debt/CF from Ops. ⓘ	3.1	0.9	0.1	1.2	0	0.3	0.5	2.5	1.4	6.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	29.5%	27.6%	13.1%	15.2%
Adj EPS ⓘ	23.9%	7.8%	6.8%	-4%
BVPSⓘ	37.7%	25.1%	13.2%	12.2%
Share Price	-	-15.3%	-15.3%	-23%

Key Financial Parameters ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26	TTM
Return on Equity % ⓘ	27.3	35.8	42	31.1	22.9	14.7	11.8	12.7	11.5	9.8	11.2
Op. Profit Mgn % ⓘ	10.4	15.3	15.1	17.5	17.4	11.9	13	13.3	12.2	11.2	11.9
Net Profit Mgn % ⓘ	6.7	9.8	8.9	10.7	11.2	6	6.1	6.8	6.2	5.2	6.2
Debt to Equity ⓘ	0.3	0.2	0	0.2	0	0	0.1	0.1	0.2	0.3	0.1
Working Cap Days ⓘ	107	109	107	140	163	134	166	189	211	215	83
Cash Conv. Cycle ⓘ	42	45	24	13	29	46	68	79	84	83	33

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Sales	233	292	516	600	709	1,483	1,656	1,831	2,080	2,396
Operating Expenses ⓘ +	209	247	439	495	586	1,307	1,441	1,587	1,826	2,127
Manufacturing Costs	6	3	13	14	21	38	49	64	77	87
Material Costs	166	197	339	372	462	1,108	1,171	1,294	1,433	1,669
Employee Cost	14	20	28	37	42	68	99	103	132	155
Other Costs ⓘ	23	28	59	73	61	93	123	127	184	217
Operating Profit ⓘ	24	45	78	105	123	176	215	243	254	269
Operating Profit Margin (%)	10.4%	15.3%	15.0%	17.5%	17.3%	11.9%	13.0%	13.3%	12.2%	11.2%
Other Income ⓘ +	1	1	1	4	9	19	14	14	15	39
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2	1	3	4	3	13	22	19	18	29
Depreciation ⓘ	4	5	12	17	23	48	63	60	67	79
Profit Before Tax ⓘ	19	40	63	88	107	136	144	178	185	203
Tax ⓘ	3	11	18	23	27	39	37	47	49	53
Profit After Tax	16	29	46	65	80	98	107	131	136	149
PAT Margin (%)	6.7%	9.9%	8.9%	10.9%	11.3%	6.6%	6.5%	7.1%	6.6%	6.2%
Adjusted EPS (₹)	3.3	6.0	9.4	12.9	15.5	17.7	19.5	23.7	24.6	26.9
Dividend Payout Ratio (%)	0%	30.30%	4.80%	3.90%	3.20%	2.80%	2.60%	2.10%	2%	1.90%

Valuation of Rossari Biotech - Consolidated

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Equity and Liabilities
Shareholders Fund +	65	94	124	286	407	802	912	1,044	1,183	1,328
Share Capital ⓘ	4	4	4	10	10	11	11	11	11	11
Reserves ⓘ	61	90	119	276	396	791	901	1,033	1,172	1,317
Debt +	22	20	4	61	0	0	64	96	175	378
Long Term Debt	2	1	1	34	0	0	35	33	100	94
Short Term Debt	20	19	3	27	0	0	29	63	75	284
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	32	40	106	97	131	186	181	219	286	323
Others Liabilities ⓘ	5	11	49	80	107	429	415	465	542	625
Total Liabilities ⓘ	124	166	283	525	645	1,417	1,572	1,825	2,187	2,655
Fixed Assets
Net Fixed Assets ⓘ +	38	45	74	94	181	607	585	578	598	784
Gross Block	76	88	86	122	234	704	743	791	878	1,133
Accumulated Depreciation	38	43	12	29	53	97	158	213	279	349
CWIP ⓘ	8	10	3	22	0	1	16	47	140	173
Investments ⓘ	0	7	0	18	0	36	51	63	84	62
Inventories	24	35	55	58	95	190	188	282	355	405
Trade Receivables	47	60	86	94	144	305	354	425	475	557
Cash Equivalents	2	1	6	127	88	52	124	30	57	92
Others Assets ⓘ	5	8	59	112	135	225	253	399	478	580
Total Assets ⓘ	124	166	283	525	645	1,417	1,572	1,825	2,187	2,655

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Cash Flow From Operating Activity ⓘ +	7	24	71	57	48	29	152	43	137	65
PBT ⓘ	19	40	63	88	107	136	144	178	185	203
Adjustment ⓘ	6	6	17	20	21	55	83	76	84	85
Changes in Working Capital ⓘ	-14	-11	11	-31	-48	-112	-28	-157	-73	-154
Tax Paid ⓘ	-3	-11	-20	-20	-31	-50	-48	-54	-59	-69
Cash Flow From Investing Activity ⓘ +	-6	-20	-36	-190	-37	-299	-181	-103	-184	-219
Capex	-6	-14	-44	-76	-56	-36	-31	-126	-158	-240
Net Investments	0	0	7	-18	14	-6	-14	-9	-18	23
Others ⓘ	0	-7	1	-96	5	-257	-136	32	-7	-2
Cash Flow From Financing Activity ⓘ +	-2	-5	-29	157	-25	292	61	16	65	186
Net Proceeds from Shares ⓘ	0	0	0	100	43	302	4	4	5	1
Net Proceeds from Borrowing ⓘ	0	0	-1	39	-34	0	45	-12	55	12
Interest Paid ⓘ	-2	-1	-2	-3	-4	-2	-6	-16	-17	-25
Dividend Paid ⓘ	0	0	-11	-3	-3	-3	-3	-3	-3	-3
Others ⓘ	-0	-4	-16	24	-27	-5	21	43	24	202
Net Cash Flow ⓘ	-0	-2	6	23	-14	22	32	-44	19	32

Financial Ratio

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	Mar'26
Ratios
ROE (%)	27.27	36.33	41.88	31.83	23.11	16.17	12.52	13.36	12.25	11.88
ROCE (%)	26.4	40.37	54.4	37.93	28.81	24.37	18.48	18.39	16.07	14.84
Asset Turnover Ratio	2	2.06	2.3	1.49	1.22	1.45	1.11	1.08	1.04	0.99
PAT to CFO Conversion(x)	0.44	0.83	1.54	0.88	0.6	0.3	1.42	0.33	1.01	0.44
Working Capital Days
Receivable Days	61.30	65.50	51.50	54.50	60.80	55	72.30	77.30	78.70	78.20
Inventory Days	38.10	35.90	31.80	34.20	39.20	35	41.50	46.70	55.80	57.60
Payable Days	66.40	67.20	78.70	99.70	90.10	52.30	57.20	56.50	64.40	66.70

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Rossari Biotech Ltd FAQs

The current trading price of Rossari Biotech on 02-Jul-2026 16:59 is ₹523.7.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jul-2026 the market cap of Rossari Biotech stood at ₹2,900.9 Cr

The latest P/E ratio of Rossari Biotech as of 01-Jul-2026 is 20.31.

The latest P/B ratio of Rossari Biotech as of 01-Jul-2026 is 2.39.

The 52-week high of Rossari Biotech is ₹767.5 and the 52-week low is ₹372.9.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Rossari Biotech is ₹1,752 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Rossari Biotech Ltd is a good quality company.

The key valuation ratios of Rossari Biotech Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Rossari Biotech Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Rossari Biotech Ltd

The company was initially incorporated as Rossari Labtech on March 6, 2003, as a partnership firm under the Indian Partnership Act, 1932, pursuant to a certificate of registration dated June 22, 2003, issued by the Registrar of Firms, Mumbai. The name of the partnership firm was changed to Rossari Biotech on December 5, 2003 and further the firm converted into a joint stock company on August 10, 2009, under part IX of the Companies Act, 1956 as Rossari Biotech Limited with a certificate of incorporation granted by the Registrar of Companies, Maharashtra at Mumbai (RoC). The company received its certificate of commencement of business on August 13, 2009.

Business area of the company

The company is one of the leading specialty chemicals manufacturing companies in India providing customized solutions to specific industrial and production requirements of its customers primarily in the FMCG, apparel, poultry and animal feed industries through its diversified product portfolio comprising home, personal care and performance chemicals; textile specialty chemicals; and animal health and nutrition products. The company’s business is organized in three main product categories - (i) home, personal care and performance chemicals; (ii) textile specialty chemicals; and (iii) animal health and nutrition products.

The company is the leading manufacturer of acrylic polymers in India and manufactures many products for its customers in the soaps and detergent, paints, inks and coatings, ceramics and tiles, water treatment chemicals and pulp and paper industries. It also manufacture institutional cleaning chemical formulations for hospitality, facility management, airports, corporates, food service, commercial laundry, malls, multiplexes, educational sector, places of worship etc. It is in advanced stages of expanding its home, personal care and performance product portfolio to water treatment formulations, specialty formulation for breweries as well as dairies. Besides, the company provides specialty chemicals for the entire value-chain of the textile industry starting from fiber, yarn to fabric, wet processing and garment processing. The company has also diversified into animal health and nutrition and currently supply poultry feed supplements and additives, pet grooming and pet treats including for weaning, infants and adult pets.

Major Events & Milestones:

2003: The company’s Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India.
2004: Established first manufacturing facility at Silvassa.
2009: Conversion of partnership firm into company.
2009: Incorporation of company.
2009: Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research.
2010: Forayed into animal health and nutrition products.
2013: Forayed into HPPC products.
2014: The company’s Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari.
2015: Lease granted by GIDC to company for setting up manufacturing facility at Dahej.
2017: The Food Safety Management System of Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015.
2018: Entered into an exclusive purchasing agreement with Hindustan Unilever.
2020: Completion of the Pre-IPO Placement.

Awards & accreditations:

2009: The erstwhile Hon’ble Union Finance Minister Pranab Mukherjee awarded ‘Corp EXCEL 2008– National mSME’ form a list of 27000 companies.
2010: Frost & Sullivan awarded ‘Customer Value Enhancement for Industrial Enzymes Market’.
2011: The Council for Fair Business Practices awarded ‘CFBP – Jamnalal Bajaj Uchit Vyavahar Puraskar for Fair Business Practices’.
2017: The India SME Forum awarded at the India SME 100 Awards for ‘scoring in the top 100 in the overall evaluation of Financial & Non - Financial Parameters amongst 33102 nominations’.
2018: Arvind awarded ‘Star Performer Award 2018’ in the Dye & Chemicals Category.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Rossari Biotech Ltd (ROSSARI)

Rossari Biotech Ltd (ROSSARI)

Rossari Biotech stock performance

Check Before You Invest

Quality

Valuation

Price Trend

DeciZen - make an informed investing decision on Rossari Biotech

1. Right Stock

2. Right Price

3. Right Time ⓘ

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Rossari Biotech - Consolidated

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Rossari Biotech Ltd FAQs

What is the share price of Rossari Biotech?

What is the market cap of Rossari Biotech?

What is the P/E ratio of Rossari Biotech?

What is the P/B ratio of Rossari Biotech?

What is the 52-week high and low of Rossari Biotech?

What is the TTM revenue of Rossari Biotech?

Is Rossari Biotech Ltd a good quality company?

Is Rossari Biotech Ltd undervalued or overvalued?

Is Rossari Biotech Ltd a good buy now?

About Rossari Biotech Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.